Idiopathic pulmonary fibrosis: state of the art for 2023
AJ Podolanczuk, CC Thomson… - European …, 2023 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …
[HTML][HTML] Home monitoring in interstitial lung diseases
MS Wijsenbeek, CC Moor, KA Johannson… - The Lancet …, 2023 - thelancet.com
The widespread use of smartphones and the internet has enabled self-monitoring and more
hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring …
hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring …
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a …
G Raghu, M Ghazipura, TR Fleming… - American journal of …, 2024 - atsjournals.org
Background: Idiopathic pulmonary fibrosis (IPF) carries significant mortality and
unpredictable progression, with limited therapeutic options. Designing trials with patient …
unpredictable progression, with limited therapeutic options. Designing trials with patient …
Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches
ON Obi, LA Saketkoo, AM Russell… - Frontiers in …, 2022 - frontiersin.org
Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology. It
affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is …
affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is …
Validity and reliability of the fatigue severity scale in a real-world interstitial lung disease cohort
KI Aronson, AM Martin-Schwarze… - American Journal of …, 2023 - atsjournals.org
Rationale: Fatigue is a common and debilitating symptom for people living with interstitial
lung disease (ILD). Studies on fatigue in ILD are limited, and little headway has been made …
lung disease (ILD). Studies on fatigue in ILD are limited, and little headway has been made …
[HTML][HTML] Idiopathic pulmonary fibrosis
T Koudstaal, MS Wijsenbeek - La Presse Médicale, 2023 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive devastating lung disease with substantial
morbidity. It is associated with cough, dyspnea and impaired quality of life. If left untreated …
morbidity. It is associated with cough, dyspnea and impaired quality of life. If left untreated …
Approach to clinical trials for the prevention of pulmonary fibrosis
JS Kim, SB Montesi, A Adegunsoye… - Annals of the …, 2023 - atsjournals.org
Page 1 of 34 supported by R01-HL-152075 from NHLBI. JAK is supported by R01HL145372
and R01HL153246 from NHLBI, W81XWH1910415 from the Department of Defense, and …
and R01HL153246 from NHLBI, W81XWH1910415 from the Department of Defense, and …
Functional status following pulmonary rehabilitation in people with interstitial lung disease: A systematic review and meta-analysis
G Rodrigues, R Santos, R Pinto… - Chronic Respiratory …, 2024 - journals.sagepub.com
Background Individuals with interstitial lung disease (ILD) often experience worsening
symptoms and activity avoidance. Limited data exists on outcome measures for assessing …
symptoms and activity avoidance. Limited data exists on outcome measures for assessing …
Supplemental oxygen therapy in interstitial lung disease: a narrative review
KP Clark, HB Degenholtz, KO Lindell… - Annals of the American …, 2023 - atsjournals.org
Patients with interstitial lung diseases (ILD) often have hypoxemia at rest and/or with
exertion, for which supplemental oxygen is commonly prescribed. The number of patients …
exertion, for which supplemental oxygen is commonly prescribed. The number of patients …